Innovative cardiac MRI in growing high-risk populations to improve outcome

Innovative cardiac MRI in growing high-risk populations to improve outcome - cardiac MRI in high-risk populations

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47375

Enrollment

320

Registered

2018-03-16

Start date

2017-08-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overgewicht en hypertensie patienten cardiomyopathy non-ischemic acquired heart disease

Interventions

Cardiac MRI cardiomyopathy

Chronic hypertension

Overweight/obesity

Type 2 diabetes mellitus

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - age 18-40 years old - no known cardiovascular disease - no co-morbidity besides the primary studied risk factor - informed consent. - no cardiac history, 25), type 2 diabetes or hypertension

Exclusion criteria

Exclusion criteria: - contra-indication for MRI and or Gadolinium - metalcontaining meterial inside the body - smoking - heart patient under treatment of a cardiologist - claustrophobia - pacemaker

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the validation of cardiac MRI cut-off values for cardiac volumes, dimensions, mass, T1 tissue values, and Strain results, in high risk populations.	—

Secondary

Measure	Time frame
Secondary endpoints include better understanding of cardiac modifications accompanying HT, DM, and OB, and more accurate diagnosis of cardiomyopathy in these groups.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)